Home Pain & sedation IV magnesium adds little for ED headache
Pain & sedation
IV magnesium adds little for ED headache
Intravenous Magnesium Sulfate for Acute Nontraumatic Headache in the Emergency Department
Annals of Emergency Medicine · Added 25 August 2026
RCT of 1,028 ED patients with acute nontraumatic headache found IV magnesium sulfate plus paracetamol achieved more frequent treatment success (78.9% vs 65.1%) but pain score differences were below clinical importance thresholds, with less rescue analgesia needed but more mild side effects.
- Study type
- RCT
- Design
- Randomised double-blind placebo-controlled trial
- Participants
- 1,028 adults with acute nontraumatic headache
- Main finding
- MgSO4 plus paracetamol: treatment success 78.9% vs 65.1% (difference 13.8%, 95% CI 8–19), but pain score differences below 1.3-point clinical importance threshold; less rescue analgesia (7.1% vs 15.3%) and more adverse events (15.4% vs 11.1%)
- Caveat
- Benefits below accepted thresholds for clinical importance; ED-based, single-centre
- Bottom line
- Context only
Why it matters in Australia (Medium relevance). ED-based analgesia trial — magnesium showed statistical but not clinically meaningful benefit for prehospital use
Learning goal
Weigh the clinical importance of intravenous magnesium as adjunct analgesia for acute nontraumatic headache in my practice.
More
- Topic: Pain & sedation
- Daily scan: 25 August 2026
Related papers on Pain & sedation
-
Low analgesia rates in sickle cell EMS pain
US nationwide cross-section of 10,023 9-1-1 ALS encounters for sickle cell disease complications in 2023 — pain scores documented in 73% but only 13.5% received any analgesia (11.7% opioids), and among patients scoring ≥7/10, contact times ≥20 min were associated with roughly five-fold more IV access and ten-fold more analgesia/opioid administration.
-
Procedural sedation consensus: clinical practice
Multidisciplinary Delphi consensus guidelines covering clinical practice for unscheduled procedural sedation.
-
Procedural sedation consensus: oversight & quality
Multidisciplinary Delphi consensus guidelines covering principles, oversight, and quality monitoring for unscheduled procedural sedation.
-
Intranasal equals subcutaneous ketamine for pain
RCT testing whether intranasal ketamine is non-inferior to subcutaneous for acute traumatic pain — both routes provided equivalent analgesia with minimal clinically important differences, though minor adverse events were more common with subcutaneous administration.